Document is current
Any future updates will be listed below
-
Authors
Nicholas, Christopher R.
Banks, Matthew I. https://orcid.org/0000-0002-1936-7529
Lennertz, Richard C.
Wenthur, Cody J. https://orcid.org/0000-0001-6043-3842
Krause, Bryan M.
Riedner, Brady A.
Smith, Richard F.
Hutson, Paul R.
Sauder, Christina J.
Dunne, John D. https://orcid.org/0000-0002-9404-7007
Roseman, Leor
Raison, Charles L. https://orcid.org/0000-0001-6687-0066
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1TR002373, UL1TR002373, UL1TR002373, UL1TR002373, UL1TR002373, UL1TR002373, UL1TR002373, UL1TR002373, UL1TR002373, UL1TR002373)
Mary Sue and Mike Shannon Fund is a philanthropic source of support for this study provided to Dr. Charles L. Raison
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
Departmental funding for Dr. Banks
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
Departmental funding for Dr. Lennertz
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
Department of Anesthesiology provided support to Dr. Krause
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
- License Information
-
More Information
Article History
Received: 5 March 2024
Revised: 19 August 2024
Accepted: 22 August 2024
First Online: 12 September 2024
Competing interests
: CRN receives consultant fees from MindMed, Lykos Therapeutics, and Usona Institute, and holds equity in Psilera as a scientific advisor. MIB receives consultant fees from VCENNA Inc. CLR receives consultant fees from Usona Institute, Novartis, and grant support from the Tiny Blue Dot Foundation. RLL, CJW, BMK, BAR, RFS, PRH, CJS, JDD and LR report no competing interests.
